Ovarian Seromucinous Carcinoma

general

A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous cells.

81

Centers

393

Active Trials

Cancer Funding

Specific Cancer Types(2)

Top Centers for Ovarian Seromucinous Carcinoma(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.0
2
NCI Comprehensive
High-Volume Research Center
72.0
3
NCI Comprehensive
High-Volume Research Center
72.0
4
High-Volume Research Center
72.0
5
NCI Comprehensive
Active Research Program
65.9
6
NCI Comprehensive
Active Research Program
65.9
7
NCI Comprehensive
Active Research Program
65.9
8
NCI Comprehensive
Active Research Program
65.9
9
NCI Comprehensive
Active Research Program
65.9
10
NCI Comprehensive
Active Research Program
65.9
11
Active Research Program
65.9
12
Active Research Program
65.9
13
NCI Comprehensive
Active Research Program
65.9
14
NCI Clinical
Active Research Program
65.9
15
NCI Comprehensive
Active Research Program
65.9
16
NCI Comprehensive
Active Research Program
65.9
17
Active Research Program
65.9
1865.9
19
Active Research Program
65.9
20
Active Research Program
65.9
21
Active Research Program
65.9
22
Active Research Program
65.9
23
NCI Comprehensive
Active Research Program
57.0
24
NCI Comprehensive
Active Research Program
57.0
25
NCI Comprehensive
Active Research Program
57.0
26
NCI Comprehensive
Active Research Program
57.0
27
NCI Comprehensive
Active Research Program
57.0
28
NCI Comprehensive
Active Research Program
57.0
29
NCI Comprehensive
Active Research Program
57.0
30
NCI Comprehensive
Active Research Program
57.0
31
NCI Comprehensive
Active Research Program
57.0
32
NCI Clinical
Active Research Program
57.0
33
NCI Comprehensive
Active Research Program
57.0
34
NCI Clinical
Active Research Program
57.0
35
NCI Comprehensive
Active Research Program
57.0
36
Active Research Program
57.0
37
NCI Comprehensive
Active Research Program
49.5
38
NCI Comprehensive
Active Research Program
49.5
39
NCI Comprehensive
Active Research Program
49.5
40
NCI Comprehensive
Active Research Program
49.5
41
NCI Comprehensive
Active Research Program
49.5
42
NCI Comprehensive
Active Research Program
49.5
43
NCI Comprehensive
Active Research Program
49.5
44
NCI Comprehensive
Active Research Program
49.5
45
Active Research Program
49.5
46
NCI Comprehensive
Active Research Program
49.5
47
Active Research Program
49.5
48
Active Research Program
49.5
49
Active Research Program
49.5
50
NCI Comprehensive
Active Research Program
42.3
51
NCI Comprehensive
Active Research Program
42.3
52
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
42.3
53
NCI Comprehensive
Active Research Program
42.3
54
NCI Comprehensive
Active Research Program
42.3
55
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
42.3
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.3
57
Active Research Program
42.3
58
Active Research Program
42.3
59
Active Research Program
42.3
6042.3
61
Active Research Program
42.3
62
Active Research Program
42.3
63
NCI Comprehensive
Active Research Program
36.2
64
NCI Comprehensive
Active Research Program
36.2
65
NCI Comprehensive
Active Research Program
36.2
66
NCI Clinical
Active Research Program
36.2
67
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
36.2
68
NCI Comprehensive
Active Research Program
36.2
69
NCI Basic_laboratory
Active Research Program
36.2
70
Active Research Program
36.2
71
Active Research Program
36.2
72
NCI Comprehensive
Contributing Research Center
31.5
73
NCI Comprehensive
Contributing Research Center
31.5
74
NCI Comprehensive
Contributing Research Center
31.5
75
NCI Clinical
Contributing Research Center
31.5
76
Contributing Research Center
31.5
77
Contributing Research Center
31.5
78
Contributing Research Center
31.5
79
BC CancerVancouver, BC
Contributing Research Center
31.5
80
NCI Comprehensive
28.7
8128.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →